Symbol: |
NACC2
|
Description: |
NACC family member 2, BEN and BTB (POZ) domain containing [Source:HGNC Symbol;Acc:23846]
|
Location: |
Chr9:138898383-138987131[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:335
Gene |
Compound |
Gen_sig |
Exp_pattern |
NACC2 |
NSC 720664 |
0.045 |
Up |
NACC2 |
NSC 720794 |
0.011 |
Up |
NACC2 |
(-)-Dibenzylnortrachelogenin |
0.026 |
Up |
NACC2 |
3'-C-ethinylcytidine |
0.007 |
Up |
NACC2 |
Pyridone-OCH3 |
0.039 |
Down |
NACC2 |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.001 |
Up |
NACC2 |
NSC 724771 |
0.007 |
Up |
NACC2 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.012 |
Up |
NACC2 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.005 |
Up |
NACC2 |
Waol A FD-211 |
0.002 |
Up |
NACC2 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.007 |
Up |
NACC2 |
NSC 726373 |
0.009 |
Down |
NACC2 |
4,11-dihydroxy-1-[4-(4-hydroxy-1-piperidinyl)butyl]-1H-napht ho[2,3-f]indole-5,10-dione |
0.041 |
Up |
NACC2 |
1-(3-diethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline |
0.002 |
Up |
NACC2 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.012 |
Up |
Expression pattern: Sensitivity / Resistance
Total:23 Current:21
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:119
Total:8 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|